SCHEMBL19973714

SCHEMBL19973714

COC(=O)c1ccccc1OCCCO

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.62
HSP90AA1 P07900 2/20 0.62
HTT P42858 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
ALDH1A1 P00352 5/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
HPGD P15428 1/20 0.58
CYP2C19 P33261 1/20 0.58
KDM4E B2RXH2 4/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
GAA P10253 1/20 0.56
LMNA P02545 3/20 0.54
SLC6A3 Q01959 3/20 0.53
GLA P06280 1/20 0.51
SLC6A4 P31645 1/20 0.51
TSHR P16473 1/20 0.50
NR1I2 O75469 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4448505 0.94 MAPT (0.59) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL6280141 0.92 HSP90AA1 (0.59) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL7956581 0.87 MAPT (0.62) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL7981719 0.87 MAPT (0.62) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL7956804 0.85 MAPT (0.60) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL6043498 0.85 MAPT (0.60) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL6770205 0.85 MAPT (0.68) MAPTHSP90AA1HTTNPSR1ALDH1A1
Benzene SCHEMBL28006415 0.85 MAPT (0.60) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL385973 0.85 HSP90AA1 (0.59) MAPTHSP90AA1HTTNPSR1ALDH1A1
SCHEMBL536427 0.85 MAPT (0.59) MAPTHSP90AA1HTTNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MAPT 3165/4885HSP90AA1 3478/4885HTT 2199/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MAPT 3165/4885HSP90AA1 3478/4885HTT 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.